Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia. - Wikidata - wikimedia - TriplyDB

Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia.

Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia.

http://www.wikidata.org/entity/Q34879022

about

Ziprasidone versus other atypical antipsychotics for schizophrenia The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.Regarding "A Risperidone-induced Prolactinoma Resolved When A Woman with Schizoaffective Disorder Switched to Ziprasidone: A Case Report".Weight gain and antipsychotics: a drug safety review.Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions.

P2860

Q24240260-63CEB6BB-DA19-4F82-976F-398F1288CF36 Q33619940-B74A39C8-097F-4E8C-832F-55CF9BED3BC6 Q36737420-54B61EC4-F209-49F9-A40F-1C3B54250583 Q38268590-25F71F9A-FFFC-448D-82DD-A6D6077425FE Q38838664-118C6ADF-BD4D-4FBA-B2C1-1C3180DE2B4F

P2860

Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia.

http://www.wikidata.org/entity/Q34879022

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Double-blind comparison of zip ...... exacerbation of schizophrenia.

@ast

Double-blind comparison of zip ...... exacerbation of schizophrenia.

@en

Double-blind comparison of zip ...... exacerbation of schizophrenia.

@nl

type

label

Double-blind comparison of zip ...... exacerbation of schizophrenia.

@ast

Double-blind comparison of zip ...... exacerbation of schizophrenia.

@en

Double-blind comparison of zip ...... exacerbation of schizophrenia.

@nl

prefLabel

Double-blind comparison of zip ...... exacerbation of schizophrenia.

@ast

Double-blind comparison of zip ...... exacerbation of schizophrenia.

@en

Double-blind comparison of zip ...... exacerbation of schizophrenia.

@nl

P1433

Q34879022-AE236739-C98B-45EC-A5FA-DF5D33D332B6

P1476

Q34879022-2F6CE630-E3ED-45F2-8AB9-17A9E4254073

P2093

Q34879022-1E0E8EBB-04BD-4FD1-AEBD-CBA41FA17213

Q34879022-26BD9B67-ED00-44A6-B066-F6E58FCC6BF0

Q34879022-33A5851F-1255-47D2-BAE5-0C3154C618FA

Q34879022-49F51CF2-DB68-4B35-A9BE-D81D589D01AB

Q34879022-4B5C41E6-2F91-4F8C-BD60-7189710CEA8E

Q34879022-6DAD4B44-526C-4286-887A-E97E36FDDAD9

Q34879022-955B51FD-ECE3-4E0D-81DC-049A94C14384

Q34879022-9FFFB167-32CF-481B-8773-CC56EC973460

Q34879022-C1D13CD7-7124-4A3F-8C89-0EAAB044BB2F

Q34879022-D0BDE0F3-73A8-4009-A676-8B9677A1FF44

P2860

Q34879022-08F014CC-BD55-41FF-92C1-34128A5FE7A2

Q34879022-0F52C6EB-8DEE-48B2-87C0-3DC6BE2F330E

Q34879022-1611202C-86CD-42AD-9964-785FF803BFE1

Q34879022-2A587B6C-2293-4D8C-A6AF-65A1FDEC2F52

Q34879022-3832C51D-BC9F-4429-B68F-9F0214574609

Q34879022-490C1730-5E28-4B9A-A4FA-CD350AB6F3F3

Q34879022-6738FF9C-05ED-4189-8352-908E65D5B09E

Q34879022-70551FB1-4A2F-4146-A347-C539B91E22A4

Q34879022-976557ED-1722-43AD-A314-11D19980CA84

Q34879022-9BC82DC9-AE3E-4077-B867-AAE610724E93

P304

Q34879022-E364301F-3038-48FD-829A-CD57A9DC7E96

P31

Q34879022-49F0E388-2A3A-4BCA-A8FB-2225417F6E3A

P356

Q34879022-91388DBA-3142-4311-841A-A0BD7260E7A6

P407

Q34879022-E859ABF3-A569-42A2-85D3-F93712675F27

P478

Q34879022-EEC3119B-6C23-4281-A29A-5C38B1C5FB22

P50

Q34879022-BF884AAC-ADA5-4D28-9FA8-8A07847E514E

P577

Q34879022-89D1DF84-1558-41FD-8FA2-4B5D82AC1BBE

P698

Q34879022-019A6929-91F4-4708-9595-CF77A7AD8496

P921

Q34879022-93205D5A-6932-4C98-A4E8-57FE33FA9F9E

P932

Q34879022-5B5D32A0-9ED3-42FC-9597-209AB119A4A1

P356

P1433

Neuropsychiatric Disease and Treatment

P1476

Double-blind comparison of zip ...... exacerbation of schizophrenia

@en

P2093

Bruce Parsons

http://www.w3.org/2001/XMLSchema#string

Cui Ma

http://www.w3.org/2001/XMLSchema#string

Gang Wang

http://www.w3.org/2001/XMLSchema#string

Hongyan Zhang

http://www.w3.org/2001/XMLSchema#string

Huafang Li

http://www.w3.org/2001/XMLSchema#string

Liang Shu

http://www.w3.org/2001/XMLSchema#string

Niufan Gu

http://www.w3.org/2001/XMLSchema#string

Shiping Xie

http://www.w3.org/2001/XMLSchema#string

Ting Li

http://www.w3.org/2001/XMLSchema#string

Wei Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

Ziprasidone in the short-term treatment of patients with schizoaffective disorder: results from two double- blind, placebo-controlled, multicenter studies.

Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group.

Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.

Risperidone in the treatment of schizophrenia.

Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group.

Antipsychotics: impact on prolactin levels.

Efficacy and safety of aripiprazole in the acute treatment of schizophrenia in Chinese patients with risperidone as an active control: a randomized trial.

Racial and ethnic factors in psychiatric research.

Neuroleptic dosage for Asians: a failure to replicate.

P304

77-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/NDT.S16664

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21552309

http://www.w3.org/2001/XMLSchema#string

P921

P932

3083980

http://www.w3.org/2001/XMLSchema#string